|
PB 92 of 2022
Arrangements as made
|
|
This instrument amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015) to include provision for the supply of two new medicines (mecasermin and somatrogon) for the treatment of children with particular conditions, consistent with recommendations of the Pharmaceutical Benefits Advisory Committee made in March 2022.
|
|
Administered by: Health and Aged Care
|